Skip to content

DR. BARBARA DECLERCQ

Active Private limited companyfounded 2020active for 6 yearsDon Boscolaan 28, 8500 KortrijkKBO/BCE: BE 0741.916.277

Lifetime

6 annual accounts with figures on one time axis
peak of €269,480 in 2025
€269,480▲ 11.8%
peak of €195,054 in 2020
€191,157▲ 12.3%
peak of €488,651 in 2022
€1,644▲ 238%
€282,174▲ 25.0%
Board1 name since 2020
1 director
Documentsfilings and deeds
08-07-202623 days before the deadline
2025micro format
Dividend €190,000Equity from €487 to €1,644Debts from €225,735 to €282,174Cash from €48,034 to €116,107

Key points

from the 2025 annual accounts

Equity

€1,644 from €488,651 in 2022

Equity fell by 100% in 3 years.

Turnover

≈ €410,000 estimated

The accounts state no turnover.

Debts

€282,174 99% of the balance sheet
Financial debts 7%Suppliers 11%Taxes and wages 1%Other 81%

Of this, €261,980 falls due within a year.

Filings

6 annual accounts since 2020
AprilJune31 JulyOctober202020222024

The last five annual accounts were filed 7 to 23 days before the end of the period.

Position in the sector

0.6%

Lower solvency than 95% of companies in human health. The sector median is 63.1%, over 21,368 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,154 companies had the same profile as DR. BARBARA DECLERCQ has now. Each dot stands for 6 companies, two years later.

96.0%
were still trading
2.3%
stopped another way
1.7%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,154 companies, not a prediction for DR. BARBARA DECLERCQ. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 20-01-2020
  • 120 sharesdeed of 27-01-2020
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0741916277
Incorporation Founding capital of €120, 120 shares · Founded by · appointed as director · published on 27-01-2020 · Gazette deed
First establishment Don Boscolaan 28, Kortrijk
All 12 events

Comparable companies

same main activity, similar in size and age
Company
DR. BARBARA DECLERCQ Kortrijk €283,819 €269,480 0.6% -
Ortho De Geest De Haan €269,195 €289,339 97.7% -
Dr. Barbara Hermans Waregem €268,646 €246,030 21.8% -
Dr. H. VAN DEN BOSSCHE Veurne €264,770 €303,353 0.8% -
THAIS DENGIS ARACA Sprimont €284,964 €270,485 19.8% -
Dr. Steffi Cattoir, anesthesie Laarne €277,771 €260,136 87.2% -
Newell Sleep Lasne €271,670 €267,114 72.4% -

These companies have the same main activity as DR. BARBARA DECLERCQ: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €265,000 and €285,000, founded between 2019 and 2020.

Official details

Source: KBO
Status
Active since 23-01-2020Normal situation
Activity
Specialist medical practiceNACE 86220and 1 other
Establishment unit
2.300.343.2218500 Kortrijk, since 23-01-2020
Financial year end
31 December
Peppol
Reachable since 19-11-2025
Company details

Annual accounts 2025

€283,819▲ 25.5%
Filing
Filed on 08-07-2026, 23 days before the end of the filing period
Financials

Insights on DR. BARBARA DECLERCQ

DR. BARBARA DECLERCQ files the micro format. That format states no turnover. The gross margin rose from €258,772 in 2020 to €269,480 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. BARBARA DECLERCQ

What is the company number of DR. BARBARA DECLERCQ?
The company number of DR. BARBARA DECLERCQ is 0741.916.277. The VAT number is the same number with BE in front: BE 0741.916.277.
Where is DR. BARBARA DECLERCQ based?
The registered office is at Don Boscolaan 28, 8500 Kortrijk.Company details
What does DR. BARBARA DECLERCQ do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. BARBARA DECLERCQ?
DR. BARBARA DECLERCQ is a private limited company (BV).
When was DR. BARBARA DECLERCQ founded?
DR. BARBARA DECLERCQ was founded on 23-01-2020.
Is DR. BARBARA DECLERCQ still active?
Yes, DR. BARBARA DECLERCQ is an active enterprise in the KBO register.
What is the turnover of DR. BARBARA DECLERCQ?
The turnover in financial year 2025 is about €410,000. This figure is estimated from the gross margin of €269,480 and 31 comparable companies (NACE 86220). It probably lies between €360,000 and €560,000.Financials
Is DR. BARBARA DECLERCQ profitable?
In financial year 2025, DR. BARBARA DECLERCQ made a profit of €191,157.
Where can I find the annual accounts of DR. BARBARA DECLERCQ?
DR. BARBARA DECLERCQ filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. BARBARA DECLERCQ due?
DR. BARBARA DECLERCQ must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.